Dr. Holger Kost

Executive Quality Management Representative at QUESTALPHA GmbH & Co. KG
  • Claim this Profile
Contact Information
Location
Eschenburg, Hesse, Germany, DE
Languages
  • English Full professional proficiency
  • French Elementary proficiency
  • German Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Germany
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Executive Quality Management Representative
      • Jan 2021 - Present

      Person Responsible for Regulatory Compliance (MDR) Person Responsible for Regulatory Compliance (MDR)

    • Germany
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • VP Quality and Regulatory
      • Apr 2019 - Present

      Person Responsible for Regulatory Compliance (MDR) Authorized Quality Management Representative Person Responsible for Regulatory Compliance (MDR) Authorized Quality Management Representative

    • Director Quality Assurance (Quality Site Head)
      • May 2017 - Mar 2019

      Quality Management Representative at largest IVD manufacturing site of the Abbott Diagnostics Division. The Wiesbaden (Germany) site has >1500 employees. Worldwide registration (inkl. USA). Quality Management Representative at largest IVD manufacturing site of the Abbott Diagnostics Division. The Wiesbaden (Germany) site has >1500 employees. Worldwide registration (inkl. USA).

    • Head of QC
      • May 2013 - Apr 2017

      Functional lead of QC and AS&T unit, including analytical, microbiology & monitoring, packaging packaging materials. Functional lead of QC and AS&T unit, including analytical, microbiology & monitoring, packaging packaging materials.

    • Switzerland
    • Pharmaceutical Manufacturing
    • Head of QC Chemistry
      • Jun 2009 - Apr 2013

      Functional lead of analytical QC (Incoming Inspection, Analytical, Biochemistry, Immunology, Stability and LIMS)80 FTE, 5 Mio€ budget

    • Deputy head of Technology Development
      • Apr 2006 - May 2009

      Development of cell culture derived influenza vaccine. Registration in Europe and US.

    • United States
    • Biotechnology
    • 100 - 200 Employee
    • Manager Process development
      • Aug 2001 - Mar 2006

      Development of immunological methods (e.g. ELISA) for the quantification of viral proteins (Influenza, HIV, HCV, SARS) Development of immunological methods (e.g. ELISA) for the quantification of viral proteins (Influenza, HIV, HCV, SARS)

Education

  • University of Giessen
    Doctor of Philosophy (Ph.D.), Biochemistry & Analytical Chemistry
    1989 - 2001

Community

You need to have a working account to view this content. Click here to join now